20 April 2026 : Database Analysis
[In Press] Population Dynamic Projections of Near Vision Loss and Refractive Disorders in China and the G20 From 1990 to 2038
Xin LiuDOI: 10.12659/MSM.951896
Med Sci Monit In Press; DOI: 10.12659/MSM.951896
Available online: 2026-04-20, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Near vision loss (NVL) and refractive disorders (RD) are vision impairments that impact quality of life and economic factors globally. Public health planning requires understanding their burdens and predicting trends.
MATERIAL AND METHODS
Using Global Burden of Disease (GBD) 2021 data, we analyzed age-standardized prevalence rates (ASPR) and disability-adjusted life year rates (ASDR) for China and the G20 from 1990 to 2021. Trends were described using actual and estimated annual percentage changes. Bayesian age-period-cohort modeling predicted disease burden from 2022 to 2038. Decomposition analysis quantified contributions from population growth, aging, and epidemiological changes.
RESULTS
NVL ASPR in China was 40 341.49 per 100 000, higher than in the G20. RD ASPR in China was 3044.90 per 100 000, lower than in the G20. Both conditions were more prevalent among women. NVL burden was highest in the 55 to 64 age group; RD burden peaked in the 80 to 84 age group. Overall, NVL showed an increasing trend (China: +1.95%; G20: +1.92%); RD showed a decreasing trend (China: -0.46%; G20: -0.36%). NVL burden is projected to continue rising, whereas RD burden will decline by 2038; both are mainly influenced by population growth.
CONCLUSIONS
We identified divergent trends for NVL and RD in China and the G20 among adults. NVL burden has increased since the mid-1990s and is projected to continue rising through 2038; RD rates have declined. Burdens remain higher in women, particularly in middle-aged (NVL) and older (RD) populations. These findings support sustained, demographically responsive eye health planning.
Keywords: Aged; Vision Disorders
Editorial
01 January 2026 : Editorial
Editorial: Increasing Awareness of Lung Cancer in Non-Smokers and Never-Smokers Challenges Current Approaches to Prevention and ScreeningDOI: 10.12659/MSM.952454
Med Sci Monit 2026; 32:e952454
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






